This report analyzes the worldwide markets for Biosensors in Medical Diagnostics in Millions of US$. The major product segments analyzed are Medical Biosensors, Glucose Biosensors, Other Medical Biosensors, Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 89 companies including many key and niche players worldwide such as Abbott Point of Care, Inc., Affinity Sensors, Neosensors Limited, Siemens Healthcare Diagnostics Inc., Animas Corp, Lifescan, Inc., Medtronic Diabetes, Roche Diagnostics Ltd., AgaMatrix Inc., Cranfield Health, LifeSensors Inc., M-Biotech, and Nova Biomedical Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Total Companies Profiled: 89 (including Divisions/Subsidiaries - 101) Region/Country Players The United States 64 Canada 5 Japan 4 Europe 23 Germany 6 The United Kingdom 11 Rest of Europe 6 Asia-Pacific (Excluding Japan) 4 Middle East 1